June 2013

Roderic Guigo: ”We do not work only to know the genome sequence but to understand how DNA works in different conditions”

The head of bioinformatics and genomics laboratory of the Centre for Genomic Regulation in Barcelona (CRG), Roderic Guigo, explained the latest developments of the ENCODE project at a conference framed in IDIBELL seminar series on 14 June. In 2003, the ENCODE project begun with the aim of knowing the human genome. The project has grown […]

Roderic Guigo: ”We do not work only to know the genome sequence but to understand how DNA works in different conditions” Read More »

Six students will live summer at IDIBELL

Six students will have the opportunity to complete their formation in one of the IDIBELL research groups. The training will last three months, from July to September. The students have finished the last course of a biomedical bachelor’s program. The Scientific Direction of IDIBELL has evaluated the applications received and has announced the awarded of

Six students will live summer at IDIBELL Read More »

Mutua Madrileña Foundation funds IDIBELL and ICO project to improve molecular diagnosis of Lynch syndrome

The Fundación Mutua Madrileña, in its 10th Call for Aids to Research, has selected a project to improve the diagnosis of Lynch syndrome led by researcher Marta Pineda, from the Hereditary Cancer research group of the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO). The aid is provided with 33,000 euros

Mutua Madrileña Foundation funds IDIBELL and ICO project to improve molecular diagnosis of Lynch syndrome Read More »

Brain illusions at Ciutadella Park

Ciutadella Park in Barcelona has hosted on 15th and 16th June, the Festival of Science and Technology. The group of cognition and brain plasticity of the IDIBELL has participated, offering many activities to discover how our brain often makes us perceive things different to reality. This is the first year that the researcher Lucía Vaquero

Brain illusions at Ciutadella Park Read More »

AECC funds a research project on Ewing sarcoma participated by IDIBELL

The Spanish Association against Cancer (AECC) has awarded an aid to research in Ewing sarcoma, a type of childhood cancer located in bone. The project has a duration of five years and has funding of one million two hundred thousand Euros. Ewing sarcoma is the second most common bone cancer and affects children and youth.

AECC funds a research project on Ewing sarcoma participated by IDIBELL Read More »

Carlos Martin: ”Nobody believed that an attenuated strain of tuberculosis could reach to clinic”

The professor of microbiology and researcher at Microbacteria Genetics group at the University of Zaragoza, Carlos Martin, explained at what stage are the first trials of the MTBVAC. The conference held on June 7 is part of the series of seminars IDIBELL. Martin explained the process of creating the vaccine, the first with attenuated TB

Carlos Martin: ”Nobody believed that an attenuated strain of tuberculosis could reach to clinic” Read More »

Find out how the brain tricks us in the Science Festival

This weekend we celebrate the Science and Technology Festival at Ciutadella’s Park, Barcelona. Researchers of the Cognition and Brain Plasticity group at IDIBELL have prepared several activities to teach the little ones as often what we see and perceive does not correspond with reality. With these experiments, aimed at people over six years, the researchers

Find out how the brain tricks us in the Science Festival Read More »

Antoni Castells: ”We need to find new tools for colon cancer screening”

Researcher Antoni Castells of the IDIBAPS explained the present and the future of screening techniques for colon cancer, the most common cancer and second leading cause of death in Spain. It was on May 31 at a conference framed in IDIBELL seminar series. “The techniques we use today, despite having limitations, are effective and cost-effective”

Antoni Castells: ”We need to find new tools for colon cancer screening” Read More »

Scroll to Top